Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.

Iddings D, Ahmad A, Elashoff D, Bilchik A.

Ann Surg Oncol. 2006 Nov;13(11):1386-92. Epub 2006 Sep 29.

PMID:
17009147
2.

Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.

Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, Fukunaga H, Miyake Y, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M.

J Clin Oncol. 2002 Oct 15;20(20):4232-41.

PMID:
12377967
3.

[Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].

Wang YX, Sun YE, Li XH, Wang ZB, Liu YL, Chen LA, Tong XY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 1;88(1):19-21. Chinese.

PMID:
18346373
4.

Metastatic lymph node size and colorectal cancer prognosis.

Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H, Kubota H, Nagasue N.

J Am Coll Surg. 2005 Jan;200(1):20-8.

PMID:
15631916
5.

Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.

Bernini A, Spencer M, Frizelle S, Madoff RD, Willmott LD, McCormick SR, Niehans GA, Ho SB, Kratzke RA.

Cancer Detect Prev. 2000;24(1):72-9.

PMID:
10757125
6.

Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.

Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H, Siewert JR.

J Clin Oncol. 2002 Feb 15;20(4):1049-55.

PMID:
11844829
7.

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.

Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D, Chen SL, Gonzalez M, Elashoff D, Morton DL.

Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7.

PMID:
17893493
8.

Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.

Lockett MA, Baron PL, O'Brien PH, Elliott BM, Robison JG, Maitre N, Metcalf JS, Cole DJ.

J Am Coll Surg. 1998 Jul;187(1):9-16.

PMID:
9660019
9.

The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.

Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, Demeester TR.

Ann Thorac Surg. 2004 Oct;78(4):1161-9; discussion 1161-9.

PMID:
15464464
10.

Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.

Ho SB, Hyslop A, Albrecht R, Jacobson A, Spencer M, Rothenberger DA, Niehans GA, D'Cunha J, Kratzke RA.

Clin Cancer Res. 2004 Sep 1;10(17):5777-84.

11.

Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer.

Wang HY, Sun JM, Lu HF, Shi DR, Ou ZL, Ren YL, Fu SQ.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):643-8.

PMID:
16681740
12.

Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.

Denninghoff VC, Kahn AG, Falco J, Curutchet HP, Elsner B.

Mol Diagn. 2004;8(4):253-8.

PMID:
15887981
13.

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS.

J Clin Oncol. 2001 Feb 15;19(4):1128-36. Erratum in: J Clin Oncol 2001 May 1;19(9):2583.

PMID:
11181678
14.
15.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
16.

Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.

Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH.

Ann Surg Oncol. 2009 Jan;16(1):113-20. doi: 10.1245/s10434-008-0121-x. Epub 2008 Oct 23.

PMID:
18949520
17.

Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.

Heeren PA, Kelder W, Blondeel I, van Westreenen HL, Hollema H, Plukker JT.

Eur J Surg Oncol. 2005 Apr;31(3):270-6.

PMID:
15780562
18.

RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients.

Kelder W, van den Berg A, van der Leij J, Bleeker W, Tiebosch AT, Grond JK, Baas PC, Plukker JT.

Scand J Gastroenterol. 2006 Sep;41(9):1073-8.

PMID:
16938721
19.

Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.

Hashimoto T, Kobayashi Y, Ishikawa Y, Tsuchiya S, Okumura S, Nakagawa K, Tokuchi Y, Hayashi M, Nishida K, Hayashi S, Hayashi J, Tsuchiya E.

Cancer Res. 2000 Nov 15;60(22):6472-8.

20.

Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma.

Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K, Nakanishi Y, Shimoda T.

Cancer. 2001 Aug 15;92(4):753-60.

PMID:
11550144
Items per page

Supplemental Content

Write to the Help Desk